Vistagen Therapeutics, Inc. (VTGN)
3.95
-0.58
(-12.80%)
USD |
NASDAQ |
Dec 11, 16:00
3.93
-0.02
(-0.51%)
After-Hours: 20:00
Vistagen Therapeutics Cash from Investing (Quarterly): -0.094M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 21.36M |
| XOMA Royalty Corp. | 58.21M |
| Omeros Corp. | -6.861M |
| GeoVax Labs, Inc. | 0.00 |
| Daré Bioscience, Inc. | -0.1747M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.76M |
| Cash from Financing (Quarterly) | 27.65M |
| Free Cash Flow | -53.96M |
| Free Cash Flow Per Share (Quarterly) | -0.3866 |
| Free Cash Flow to Equity (Quarterly) | -13.33M |
| Free Cash Flow to Firm (Quarterly) | -13.82M |
| Free Cash Flow Yield | -42.35% |